News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Smith & Nephew Inc. (SNN)'s Low Bid For ArthroCare Corporation (ARTC) Gives Competitors A Shot At Rival Offers


2/7/2014 7:34:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Smith & Nephew Plc’s bid for ArthroCare Corp. (ARTC), at the lowest premium for a medical-instruments company since the 1990s, is giving Stryker Corp. or Johnson & Johnson a shot at a rival offer. ArthroCare, which makes products used in sports medicine for minimally invasive surgery, closed yesterday 99 cents above the $48.25-a-share bid from Smith & Nephew as some investors bet on higher proposals. Stryker, which acquired technology for robot-assisted surgery last year, and J&J, the world’s biggest maker of health-care products, are the most likely candidates to counter the $1.7 billion offer, said William Blair & Co.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES